| |
|
HCV in USA Current Status
|
| |
| |
At the end of 2018, almost 85% of Veterans at increased risk for HCV had been tested, compared to 50% for the general U.S. population. Currently, fewer than 25,000 Veterans in VA care remain to be treated. Because of this historic effort, Veterans cured of HCV are estimated to be 72% less likely to develop liver cancer. Through Veteran advocacy, VA leadership and the support of Congress, VA implemented an aggressive program to treat Veterans with HCV who were both willing and able to be treated. This included extensive outreach to all Veterans in VA known to have HCV infection, and increased testing of those at highest risk for HCV.
"VA is so far ahead of private health care systems on hepatitis C treatment and innovation in care delivery, and also in treating advanced liver disease." -Dana Smothers, Hepatology Nurse Care Coordinator at VA Portland.
Reduction needed to meet 2020 goal: A 76.0% reduction from the 2017 reported acute HCV infection rate is needed to meet the 2020 goal of 0.25 cases per 100,000 U.S. population.
USA - Acute HCV Increasing
Underestimation of Liver Disease in the Medicare Eligible Population - (11/25/19)
USA Amongst The Worst in Path Towards HCV Elimination - EASL: Global timing of hepatitis C virus elimination: estimating the year countries will achieve the World Health Organization elimination targets - (04/15/19)
HCV Elimination Off-Track WHO Targets/Countries Estimates - Global timing of hepatitis C virus elimination: estimating the year countries will achieve the World Health Organization elimination targets - (04/15/19)
| |
| |
| |
|
|
|
